Photo taken from Ignacio Gil-Bazo/LinkedIn
Mar 10, 2024, 12:13
Ignacio Gil-Bazo: A mechanism of action through which anti-TIGIT inhibitors can modify immunosuppressive tumor microenvironments
Ignacio Gil-Bazo, Scientific Director and Head of Department of Oncology at Valenciano Institute of Oncology, shared on LinkedIn:
“Finally out! Really interesting paper recently published in Nature in which the results reveal a mechanism of action through which anti-TIGIT inhibitors can modify immunosuppressive tumor microenvironments. Furthermore, it’s shown how FcγR engagement might play a relevant role in anti-TIGIT antibody development. Very happy to co-author this article with other international colleagues and, in special, with my Spanish friends Enriqueta Felip and Delvys Rodriguez-Abreu.
For direct access to the paper follow this link.”
Source: Ignacio Gil-Bazo/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 22, 2024, 08:13
Nov 21, 2024, 21:47
Nov 21, 2024, 21:40
Nov 21, 2024, 21:36
Nov 21, 2024, 21:27
Nov 21, 2024, 21:23
Nov 21, 2024, 21:17
Nov 21, 2024, 21:07